{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T05:58:15Z","timestamp":1777874295719,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Probes"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.mcp.2026.102067","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T16:43:43Z","timestamp":1770914623000},"page":"102067","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The function and mechanism of LINC01583 on Osimertinib resistance in non-small cell lung cancer"],"prefix":"10.1016","volume":"87","author":[{"given":"Xiaoyue","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.mcp.2026.102067_bib1","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1056\/NEJMoa2304875","article-title":"Perioperative durvalumab for resectable non-small-cell lung cancer","volume":"389","author":"Heymach","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"10.1016\/j.mcp.2026.102067_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13236005","article-title":"The MEK\/ERK\/miR-21 signaling is critical in osimertinib resistance in EGFR-mutant non-small cell lung cancer cells","volume":"13","author":"Huang","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"suppl_1","key":"10.1016\/j.mcp.2026.102067_bib3","doi-asserted-by":"crossref","first-page":"i20","DOI":"10.1093\/annonc\/mdx704","article-title":"Osimertinib and other third-generation EGFR TKI in EGFR-mutant NSCLC patients","volume":"29","author":"Remon","year":"2018","journal-title":"Ann. Oncol. : official journal of the European Society for Medical Oncology"},{"issue":"7","key":"10.1016\/j.mcp.2026.102067_bib4","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJMoa2402614","article-title":"Osimertinib after chemoradiotherapy in stage III EGFR -Mutated NSCLC","volume":"391","author":"Lu","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mcp.2026.102067_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2023.102557","article-title":"Acquired resistance mechanisms to osimertinib: the constant battle","volume":"116","author":"Zalaquett","year":"2023","journal-title":"Cancer Treat Rev."},{"issue":"11","key":"10.1016\/j.mcp.2026.102067_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.104161","article-title":"P-glycoprotein (P-gp)-driven cancer drug resistance: biological profile, non-coding RNAs, drugs and nanomodulators","volume":"29","author":"Guo","year":"2024","journal-title":"Drug Discov. Today"},{"issue":"29","key":"10.1016\/j.mcp.2026.102067_bib7","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.3748\/wjg.v24.i29.3222","article-title":"ATP-binding cassette transporters in progression and clinical outcome of pancreatic cancer: what is the way forward?","volume":"24","author":"Adamska","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.mcp.2026.102067_bib8","article-title":"LncRNA in gastric cancer drug resistance: deciphering the therapeutic strategies","volume":"15","author":"Liu","year":"2025","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.mcp.2026.102067_bib9","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.cell.2011.07.014","article-title":"A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?","volume":"146","author":"Salmena","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.mcp.2026.102067_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2021.104633","article-title":"LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p\/DCLK1 axis","volume":"120","author":"Ge","year":"2021","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.mcp.2026.102067_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109309","article-title":"LncRNA FENDRR suppresses the progression of NSCLC via regulating miR-761\/TIMP2 axis","volume":"118","author":"Zhang","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.mcp.2026.102067_bib12","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s13046-023-02875-y","article-title":"Lnc AC016727.1\/BACH1\/HIF-1 \u03b1 signal loop promotes the progression of non-small cell lung cancer","volume":"42","author":"Zhang","year":"2023","journal-title":"J. Exp. Clin. Cancer Res. : CR"},{"issue":"2","key":"10.1016\/j.mcp.2026.102067_bib13","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","article-title":"Gene regulation by long non-coding RNAs and its biological functions","volume":"22","author":"Statello","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"26","key":"10.1016\/j.mcp.2026.102067_bib14","doi-asserted-by":"crossref","first-page":"7637","DOI":"10.1016\/j.cell.2024.10.021","article-title":"Transcriptome-scale RNA-targeting CRISPR screens reveal essential lncRNAs in human cells","volume":"187","author":"Liang","year":"2024","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.mcp.2026.102067_bib15","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1159\/000494868","article-title":"A Six-LncRNA expression signature associated with prognosis of colorectal cancer patients","volume":"50","author":"Zhao","year":"2018","journal-title":"Cell. Physiol. Biochem. : international journal of experimental cellular physiology, biochemistry, and pharmacology"},{"key":"10.1016\/j.mcp.2026.102067_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1019451","article-title":"Feiyanning formula modulates the molecular mechanism of osimertinib resistance in lung cancer by regulating the Wnt\/\u03b2-catenin pathway","volume":"13","author":"Sang","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"12","key":"10.1016\/j.mcp.2026.102067_bib17","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1038\/s41588-023-01568-8","article-title":"Super-enhancer RNA m 6 A promotes local chromatin accessibility and oncogene transcription in pancreatic ductal adenocarcinoma","volume":"55","author":"Li","year":"2023","journal-title":"Nat. Genet."},{"issue":"11","key":"10.1016\/j.mcp.2026.102067_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adk0785","article-title":"MLL1 regulates cytokine-driven cell migration and metastasis","volume":"10","author":"Nair","year":"2024","journal-title":"Sci. Adv."},{"issue":"11","key":"10.1016\/j.mcp.2026.102067_bib19","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1111\/jcmm.17333","article-title":"FOXO4 peptide targets myofibroblast ameliorates bleomycin-induced pulmonary fibrosis in mice through ECM-receptor interaction pathway","volume":"26","author":"Han","year":"2022","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.mcp.2026.102067_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13207","article-title":"Wnt and Neuregulin1\/ErbB signalling extends 3D culture of hormone responsive mammary organoids","volume":"7","author":"Jard\u00e9","year":"2016","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.mcp.2026.102067_bib21","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201948058","article-title":"CDK12 drives breast tumor initiation and trastuzumab resistance via WNT and IRS1-ErbB-PI3K signaling","volume":"20","author":"Choi","year":"2019","journal-title":"EMBO Rep."},{"issue":"8","key":"10.1016\/j.mcp.2026.102067_bib22","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrc3775","article-title":"Non-small-cell lung cancers: a heterogeneous set of diseases","volume":"14","author":"Chen","year":"2014","journal-title":"Nat. Rev. Cancer"},{"issue":"7","key":"10.1016\/j.mcp.2026.102067_bib23","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.6879","article-title":"Association of survival and immune-related biomarkers with immunotherapy in patients with non-small cell lung cancer: a meta-analysis and individual patient-level analysis","volume":"2","author":"Yu","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.mcp.2026.102067_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2025.108589","article-title":"Investigation of cardiotoxicity in patients treated with osimertinib: findings from the OSI-FACT study","volume":"204","author":"Okada","year":"2025","journal-title":"Lung Cancer"},{"issue":"3","key":"10.1016\/j.mcp.2026.102067_bib25","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jtho.2023.10.017","article-title":"MUC1-C is a common driver of acquired osimertinib resistance in NSCLC","volume":"19","author":"Haratake","year":"2024","journal-title":"J. Thorac. Oncol. : official publication of the International Association for the Study of Lung Cancer"},{"issue":"1","key":"10.1016\/j.mcp.2026.102067_bib26","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s12931-020-01477-y","article-title":"FGL1 regulates acquired resistance to gefitinib by inhibiting apoptosis in non-small cell lung cancer","volume":"21","author":"Sun","year":"2020","journal-title":"Respir. Res."},{"issue":"1","key":"10.1016\/j.mcp.2026.102067_bib27","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1186\/s12935-021-02115-3","article-title":"LncRNA OGFRP1 acts as an oncogene in NSCLC via miR-4640-5p\/eIF5A axis","volume":"21","author":"Liu","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.mcp.2026.102067_bib28","doi-asserted-by":"crossref","first-page":"6422","DOI":"10.1038\/s41467-020-20222-z","article-title":"The epigenetic regulator Mll1 is required for Wnt-driven intestinal tumorigenesis and cancer stemness","volume":"11","author":"Grinat","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.mcp.2026.102067_bib29","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s13059-023-03108-3","article-title":"Cooperation of MLL1 and Jun in controlling H3K4me3 on enhancers in colorectal cancer","volume":"24","author":"Lin","year":"2023","journal-title":"Genome Biol."},{"issue":"1","key":"10.1016\/j.mcp.2026.102067_bib30","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/s42003-024-07339-3","article-title":"Methylation-modulated PFTK1 regulates gefitinib resistance via Wnt\/\u03b2-catenin signaling in EGFR mutant non-small-cell lung cancer cells","volume":"7","author":"Jia","year":"2024","journal-title":"Commun. Biol."},{"issue":"1","key":"10.1016\/j.mcp.2026.102067_bib31","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1038\/s41467-018-06162-9","article-title":"Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancer","volume":"9","author":"Wagner","year":"2018","journal-title":"Nat. Commun."},{"issue":"23","key":"10.1016\/j.mcp.2026.102067_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20235914","article-title":"Emetine synergizes with cisplatin to enhance anti-cancer efficacy against lung cancer cells","volume":"20","author":"Wu","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.mcp.2026.102067_bib33","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.3892\/or.2013.2597","article-title":"CHD8 is an independent prognostic indicator that regulates Wnt\/\u03b2-catenin signaling and the cell cycle in gastric cancer","volume":"30","author":"Sawada","year":"2013","journal-title":"Oncol. Rep."},{"issue":"12","key":"10.1016\/j.mcp.2026.102067_bib34","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.neo.2014.10.003","article-title":"Frequent disruption of chromodomain helicase DNA-binding protein 8 (CHD8) and functionally associated chromatin regulators in prostate cancer","volume":"16","author":"Damaschke","year":"2014","journal-title":"Neoplasia"},{"issue":"1","key":"10.1016\/j.mcp.2026.102067_bib35","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s12672-022-00489-y","article-title":"Comprehensive analysis of the expression, prognosis, and immune infiltrates for CHDs in human lung cancer","volume":"13","author":"Lv","year":"2022","journal-title":"Discov. Oncol."}],"container-title":["Molecular and Cellular Probes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890850826000071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890850826000071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:33:16Z","timestamp":1777577596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890850826000071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":35,"alternative-id":["S0890850826000071"],"URL":"https:\/\/doi.org\/10.1016\/j.mcp.2026.102067","relation":{},"ISSN":["0890-8508"],"issn-type":[{"value":"0890-8508","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The function and mechanism of LINC01583 on Osimertinib resistance in non-small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Probes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcp.2026.102067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102067"}}